249 results found.
                    
BARE BONES® - April 29, 2014
Globus Medical reported 1Q14 sales of US $114.2MM, +8.8% from 1Q13. (U.S. +5.6%, ex-U.S. +43%) (
1Q14 Revenue: Globus Medical
$114.2MM, +9% (U.S. $101.7MM, +6%; ex-U.S. $12.5MM, +43%) Innovative Fusion $66.8MM, +9% Disruptive Technology $47.4MM, +9%   Growth impacted by severe U.S .weather Price pressure remains in low- to mid-s...
4Q13/2013 Revenue: Bacterin
4Q13 tissue revenue: $8.3MM, +2% 2013 tissue revenue: $33.1MM, flat Business model going forward: direct sales to orthopaedics and neurosurgery via hybrid model; exploring private label relationships Increased productivity: 25 sal...
BARE BONES® - February 27, 2014
Globus Medical posted 4Q13 sales of US $115.2MM, +14.6% from 4Q12, and 2013 sales of $434.5MM, +12.6% vs. 2012. (
4Q13/2013 Revenue: Globus Medical
4Q13 revenue: $115.2MM, +15% (U.S. $104.1MM, +13%; ex-U.S. $11.1MM, +29%) Innovative Fusion $67.1MM, +15% Disruptive Technology $48.1MM, +14%   CREO pedicle screw + increased reps supported growth ...
4Q13/2013 Revenue: Mazor Robotics
4Q13 revenue: $5.7MM, +111% (U.S. $4.2MM, +200%; ex-U.S. $1.5MM, +15%) 2013 revenue: $20.0MM, +64% Sold 23 systems globally; installed base now 63 (34 in U.S.) 65% of spine cases using Renaissance were multi-level/complex, with 1/...
BARE BONES® - January 14, 2014
Globus Medical announced preliminary 4Q13 sales of US $115.2MM, +14.6% vs. 4Q12, and preliminary 2013 sales of $434.5MM, +12.6% from 2012. (
BARE BONES® - January 9, 2014
Globus Medical (GMED) acquired Excelsius Surgical, developer of a next-generation surgical robotic positioning platform for spine and other applications. The robotic Excelsius Surgical system supports navigation, surgi...
2013: Who, What, Where and When in an Orthopaedic Year
Before we dive into 2014, let’s review what 2013 wrought. We’ve collected the start-ups, expansions and closures, mergers and acquisitions, fundings, first 510(k)s and products launched across the orthopaedic universe in the preceding 12 months. (Please note, start-ups, first 510(k...
BARE BONES® - December 24, 2013
Globus Medical was assigned U.S. Patent No. 8,613,759, titled “Transverse fixation device for spinal fixation systems.” (
BARE BONES® - October 31, 2013
Globus Medical posted 3Q13 sales of US $107.2MM, +13% from 3Q12. (U.S. +13%, ex-U.S. +19%) (
3Q13 Revenue: Globus Medical
$107.2MM, +13% (U.S. $98.1MM, +13%; ex-U.S. $9.1MM, +19%) Disruptive Technology $45MM, +21% Innovative Fusion $63MM, +8%   Pricing pressure remains in low to middle single digits Payor pushback seems to h...
BARE BONES® - October 15, 2013
Globus Medical (GMED) received an FDA Warning Letter, dated 9/27/13, citing deficiencies in response to observations relative to MicroFuse® putty, cl...
Web Exclusive: Highlights from THE SPINE MARKET report
In 2012, revenues generated by global sales of spinal implants and instrumentation reached an estimated $7.35 billion. Though historic double-digit growth in the segment flattened in 2010, looking ahead, conservative increases should occur based upon a shift in focus to more cervical discs, la...
BARE BONES® - October 3, 2013
Globus Medical announced launch of the CREO™ next generation pedicle screw platform. CREO pedicle screws are available in modular and pre-assembled versions with top-loading, side loading
BARE BONES® - August 1, 2013
Globus Medical reported 2Q13 sales of US $107MM, +12% from 2Q12. (U.S. +11%, ex-U.S. +20%) (
2Q13 Revenue: Globus Medical
$107MM, +12% (U.S. $98.1MM, +11%; ex-U.S. $8.9MM, +20%) Disruptive Technology $44MM, +27% Innovative Fusion $63MM, +3%   Payer pushback appears to have stabilized Pricing pressure remains in low- to mid-s...
BARE BONES® - June 21, 2013
Globus Medical commenced launch of the LATIS™ minimally invasive lumbar interbody fusion spacer for the treatment of degenerative disc disease. Inserted through an MIS transforaminal approach
BARE BONES® - June 17, 2013
A Federal jury awarded DePuy Synthes US $16MM in damages in a patent infringement trial vs. Globus Medical (GMED). The jury also determined the validity of DePuy Synthes' U.S. Patents No.
BARE BONES® - May 17, 2013
Globus Medical filed a suit against DePuy Synthes, alleging willful infringment of U.S. Patent No. 8,328,872 with the Zero-P VA intervertebral fusion implant. (
BARE BONES® - May 10, 2013
Globus Medical commenced launch of the FORTIFY® I expandable corpectomy spacer, featuring integrated screws for further stability in addition to supplemental fixation. The de...
BARE BONES® - May 2, 2013
Globus Medical reported 1Q13 sales of US $105MM, +10.9% from 1Q12. (U.S. +9.4%, ex-U.S. +30%) (
1Q13 Revenue: Globus Medical
$105MM, +11% (U.S. $96.3MM, +9%; ex-U.S. $8.7MM, +30%) Innovative Fusion $61.3MM, -0.3% Disruptive Technologies $43.7MM, +29% Algea Therapies $1MM   Have attracted several high-quality sales reps from lar...
BARE BONES® - February 27, 2013
Globus Medical posted 4Q12 sales of US $100.5MM, +14% from 4Q11, and 2012 sales of $386.0MM, +16% vs. 2011. (
4Q12 and 2012 Revenue: Globus Medical
$386.0MM, +16% (U.S. $355.6MM, +14%; ex-U.S. $30.4MM, +49%) Fusion $238.7MM, +6% Disruptive Technology $147.3MM, +38% 4Q12 revenue: $100.5MM, +14% (U.S. $91.9MM, +13%; ex-U.S. $8.6MM, +37%) Fusion $58.2MM, +3%
  • ORTHOWORLD INC.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group